Glycomics/Glycobiology market Is Projected To Witness Growth Based On Technological Advancements In Glycomics Instruments Till 2025:Grand View Research,inc.
The global glycomics/glycobiology market is
expected to reach USD 2.1 billion by 2025, according to a new report by Grand
View Research, Inc. Increasing investment in R&D by research institutes and
pharmaceutical & biotechnology companies has been a major factor driving
market growth. In addition, technological advancement has led to increased
demand for advanced glycomics products for drug discovery & development,
diagnostics, and oncology research.
Escalating popularity of
personalized medicines for the treatment of several severe chronic diseases and
genetic disorders is another major factor contributing toward the growth.
Personalized medicines involve the application of glycomics for the study of
structure and function of glycans that are attached to biomolecules. Glycans
play a crucial role in modulating various biological processes and their
assessment can help determine the susceptibility to diseases & response to
treatment. Thus, application of glycobiology products is expected to rise in
near future, owing to their high potential in personalized medicine.
Untapped opportunities in
developing regions, including Asia Pacific and Africa, are another major factor
supporting the growth of the glycomics market. Glycomics research is important
for comprehensive study of glycomes to understand the cellular signaling
pathways, cell functions, genetic structure, and physiological &
pathological aspects. Glycomics research has become more popular these days due
to its advantages over genomic/proteomic analysis that cannot be used to study
many pathological processes. Thus, the demand for advanced glycomics products
by researchers and healthcare professionals is expected to fuel the sector
growth.
Browse full research report on Glycomics/Glycobiology
market: http://www.grandviewresearch.com/industry-analysis/glycobiology-market
Further Key Findings From
the Report Suggest:
- Enzymes segment is the fastest growing segment of the
glycobiology market in 2016, due to its huge application in research &
diagnostics and repetitive purchase of these products
- In the application segment, drug discovery &
development accounted for the largest revenue share in 2016, owing to the
growing focus on novel drug development and demand for personalized
medicines
- The academic and research institutes dominated in
terms of revenue in 2016, owing to the large focus on glycobiology
research and proteomics study
- The North America glycobiology market is the leading
regional sector and expected to dominate the market during forecast period
- Existence of large number of research laboratories,
pharmaceutical companies, and biotechnology companies in North America
region is the major reason for the high demand for glycobiology products
in this region
- The Asia Pacific glycobiology market is expected to
grow at the highest growth rate during the forecast period
- Some of the major players include Danaher; ProZyme;
Shimadzu Corporation; Agilent Technologies; Bruker; Merck KGaA; Takara
Bio, Inc.; New England Biolabs; ThermoFisher Scientific, Inc.; and Waters
Corporation
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global
glycomics/glycobiology market on the basis of product, application, end-use,
and region:
Glycomics/Glycobiology Product Outlook (Revenue, USD
Million; 2014 - 2025)
- Instruments
- Mass
spectrometers
- HPLC
- MALDI-TOF
- Array
systems
- Others
- Reagents
- Glycoproteins
- Monosaccharides
- Oligosaccharides
- Others
- Kits
- Glycan
labeling kits
- Glycan
purification kits
- Glycan
release kits
- Others
- Enzymes
- Glycosidases
- Glycosyl
transferases
- Neuraminidases
- Sialyl
transferases
- Others
Glycomics/Glycobiology Application Outlook (Revenue,
USD Million; 2014 - 2025)
- Drug
discovery & development
- Diagnostics
- Others
Glycomics/Glycobiology End-use Outlook (Revenue, USD
Million; 2014 - 2025)
- Academic
and research institutes
- Pharmaceutical
and biotechnology companies
- CROs
Glycomics/GlycobiologyRegional Outlook (Revenue, USD
Million; 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
Access Press Release
By Grand View Research: http://www.grandviewresearch.com/press-release/global-glycomics-glycobiology-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment